From the Agenda

Medical Affairs,Merck Serono

2017-06-20 05:04:00

Dr Francois Xavier Frapaise

VP Clin. Dev., PV,

Dr. Francois-Xavier Frapaise, M.D has over thirty years of international drug development, strategic planning and marketing experience at major pharmaceutical companies including Sanofi, Bayer and Abbott; he has hold multiple C-level positions (CSO,CMO,CEO) in different Pharmacos in the US and Europe.  He  is currently heading Clinical Development, Medical Affairs and Pharmacovigilance at Merck KGaA Biosimilars Division; he has extensive experience of biosimilars development (Boehringer-Ingelheim, Pfenex); he has been the Chief Scientific Officer and Senior Vice President of Optimer .
He served as the Chief Executive Officer and President of Asphelia Pharmaceuticals, Inc. from August 2007 to 2008. Dr. Frapaise served as Vice President of Research and Development and Corporate Officer of Tap Pharmaceutical Products Inc.,as the Chief Medical Officer of Ocera Therapeutics, as Vice President of Scientific Affairs at Abbott International , as Head of Medical Affairs at Bayer Europe, Medical Director at Bayer France, Vice President of R&D at Delagrange, Head of Anti-thrombotics Strategic Marketing at Sanofi, Medical Director at Choay.
Dr. Frapaise holds an M.D. degree from Faculté de Médecine René Descartes Paris France, and is a INSEAD alumni.
Dr. Frapaise held an academic position at the Thrombosis Research Center at the Loyola Medical Center in Maywood (IL).